As of 2025-09-15, the Relative Valuation of Denali Therapeutics Inc (DNLI) is (57.54) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.19 USD, the upside of Denali Therapeutics Inc based on Relative Valuation is -505.5%.
The range of the Relative Valuation is (47.88) - (60.09) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.6x - 20.8x | 18.2x |
| Forward P/E multiples | 16.6x - 26.6x | 21.6x |
| Fair Price | (47.88) - (60.09) | (57.54) |
| Upside | -437.4% - -523.4% | -505.5% |
| Date | P/E |
| 2025-09-11 | -5.13 |
| 2025-09-10 | -5.06 |
| 2025-09-09 | -5.31 |
| 2025-09-08 | -5.36 |
| 2025-09-05 | -5.34 |
| 2025-09-04 | -5.11 |
| 2025-09-03 | -5.29 |
| 2025-09-02 | -5.34 |
| 2025-08-29 | -5.28 |
| 2025-08-28 | -5.41 |
| 2025-08-27 | -5.40 |
| 2025-08-26 | -5.38 |
| 2025-08-25 | -5.38 |
| 2025-08-22 | -5.36 |
| 2025-08-21 | -5.27 |
| 2025-08-20 | -5.02 |
| 2025-08-19 | -5.12 |
| 2025-08-18 | -5.13 |
| 2025-08-15 | -5.08 |
| 2025-08-14 | -5.00 |
| 2025-08-13 | -5.12 |
| 2025-08-12 | -4.57 |
| 2025-08-11 | -4.81 |
| 2025-08-08 | -4.83 |
| 2025-08-07 | -4.92 |
| 2025-08-06 | -4.96 |
| 2025-08-05 | -4.94 |
| 2025-08-04 | -4.99 |
| 2025-08-01 | -4.65 |
| 2025-07-31 | -4.78 |
| 2025-07-30 | -4.73 |
| 2025-07-29 | -4.71 |
| 2025-07-28 | -4.71 |
| 2025-07-25 | -4.73 |
| 2025-07-24 | -4.95 |
| 2025-07-23 | -5.00 |
| 2025-07-22 | -4.80 |
| 2025-07-21 | -4.78 |
| 2025-07-18 | -4.84 |
| 2025-07-17 | -5.02 |
| 2025-07-16 | -5.14 |
| 2025-07-15 | -4.90 |
| 2025-07-14 | -5.08 |
| 2025-07-11 | -5.02 |
| 2025-07-10 | -5.31 |
| 2025-07-09 | -5.19 |
| 2025-07-08 | -4.96 |
| 2025-07-07 | -4.93 |
| 2025-07-03 | -5.08 |
| 2025-07-02 | -5.15 |